Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 18.00
Ask: 19.00
Change: -0.75 (-3.90%)
Spread: 1.00 (5.556%)
Open: 19.25
High: 19.25
Low: 18.50
Prev. Close: 19.25
TEAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re support to reject possible offer by TEAM

16 Apr 2021 11:18

RNS Number : 7504V
Tavistock Investments PLC
16 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

CERTAIN INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS AMENDED BY MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.  UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

TEAM PLC HAS NOT ANNOUNCED A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

 

 

Tavistock Investments Plc

 

("Tavistock" or the "Company")

 

 Update re statements of intent from shareholders to reject any possible offer by TEAM plc

 

16 April 2021

 

The Board of Tavistock announces that it has received further letters from Paul Winfield, Hamon Capital Limited, Quay Limited, Clermont Limited and Mrs A. J. Lewis stating their intention to reject the possible all share offer by TEAM plc ("TEAM") for the issued and to be issued share capital of Tavistock (the "Possible Offer").

 

These letters of intent (which are non-binding) represent, in aggregate, 7.60% of the Company's issued share capital and when taken with the previous letters of intent (as announced on 14 April 2021 and 15 April 2021 and set out in the table below) represent 34.10% of the Company's issued share capital. As also announced on 14 April 2021, the Board of Tavistock, who beneficially own, in aggregate, 97,337,016 Tavistock Shares, representing 16.01% of the Company's issued share capital, would also not be minded to recommend or accept any offer from TEAM were one to be made at the level of the Possible Offer. Accordingly, taking the Board of Tavistock's holdings together with the shares in respect of which the Company has received indications of intent to date, this represents 50.12% of the Company's issued share capital that would not accept an offer were one to be made at the level of the Possible Offer.

 

Since announcing the Possible Offer on 23 March 2021, TEAM has, up until 15 April 2021 (being the latest date prior to the publication of this announcement), announced that it has received non-binding letters of intent and an irrevocable undertaking in support of the Possible Offer from shareholders representing in aggregate, 15.03% of the Company's issued share capital.

 

Further details of the Tavistock letters of intent are set out below.

 

The Board of Tavistock remains of the view that the approach made by TEAM is without merit for the reasons previously stated, namely:

 1) the Possible Offer significantly undervalues Tavistock's business;

 

2) the Board of Tavistock does not believe there to be any commercial logic to justify a combination of the two businesses, and

 

3) the Board of Tavistock does not consider that a paper-only offer, particularly one made using illiquid shares, is in the interests of the Company's shareholders.

 

Tavistock released a year-end trading update on 8 April 2021 noting that the Company has achieved a strong close to the financial year ended on 31 March 2021.

 

The Tavistock letters of intent confirm that the relevant shareholders are not in favour of the Possible Offer, details of which were announced by TEAM on 23 March 2021, and they intend to reject any potential offer to be made by TEAM. The letters go on to state that the relevant shareholders continue to support Tavistock's management team and its current strategy.

 

The table below sets out details of the Tavistock letters of intent that have been received from shareholders to date and includes corrections to the number of shares covered by Mr McGregor's and Mr King's letters which had previously been understated:

 

Tavistock shareholder

Number of Tavistock Shares covered by letter of intent

Percentage of Tavistock Shares covered by letter of intent

Andrew Staley

55,953,204

9.21

Hamon Capital Limited

30,000,000

4.94

Kevin Mee

27,475,963

4.52

Paul Millott

26,902,417

4.43

Malcolm Harper

13,200,000

2.17

Quay Limited

10,982,000

1.81

Ben Raven*

8,845,458

1.46

Neil Thomas

7,742,338

1.27

Jeremy Allard

7,120,735

1.17

James King

4,233,024

0.70

Paul Winfield

3,936,556

0.65

Jamie Raven*

2,624,876

0.43

Nicholas Cooling

1,875,000

0.31

Christopher Halford

1,457,981

0.24

Andrew Ross

985,083

0.16

Mrs A.J.Lewis

769,231

0.13

Estate of Alan Raven (deceased)

628,570

0.10

Clermont Limited

491,000

0.08

Andrew Fouracres

312,366

0.05

Gregor Preston

284,190

0.05

Kathryn McKimmie

330,000

0.05

John McKimmie

240,000

0.04

Mark Evans

250,000

0.04

Mark Wilson

250,000

0.04

Steven McGregor

264,400

0.04

Natalie Theobold

133,333

0.02

 

 

 

TOTAL

207,287,725

34.10

 

* Ben Raven and Jamie Raven are deemed to be acting in concert with the Directors of Tavistock

 

Enquiries:

 

Tavistock Investments Plc

Oliver Cooke

Brian Raven

 

Tel: 01753 867000

Allenby Capital Limited

(Financial Adviser, Nominated Adviser and Broker to Tavistock)

Corporate Finance:

Nick Naylor, David Worlidge, Nick Athanas, Liz Kirchner

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

Powerscourt (PR adviser to Tavistock)

Gilly Lock

Chloe Retief

Tel: 07711 380 007

020 7250 1446

 

 

Disclosure requirements of the Takeover Code

 

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk , including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Takeover Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make a Dealing Disclosure.

 

 Additional information

 

Allenby Capital Limited ("Allenby Capital"), is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Allenby Capital is acting as financial adviser exclusively for Tavistock and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than Tavistock for providing the protections afforded to clients of Allenby Capital or its affiliates, or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

 

Publication on a website

 

This announcement and the documents required to be published pursuant to Rule 26 of the Code will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Tavistock's website at https://tavistockinvestments.com/ promptly and in any event by no later than 12 noon on the Business Day following the date of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDIFMMTMTBBBAB
Date   Source Headline
17th Apr 20244:00 pmRNSResult of AGM and Issue of New Shares
12th Apr 20247:00 amRNSResult of WRAP Retail Offer
9th Apr 20247:00 amRNSNotice of Investor Presentation
5th Apr 202411:15 amRNSDirector/PDMR Shareholding
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:25 pmRNSResult of Subscription
28th Mar 20247:02 amRNSWrap Retail Offer
28th Mar 20247:01 amRNSPlacing, Subscription and Wrap Retail Offer
28th Mar 20247:00 amRNSFinal Results
29th Feb 20244:00 pmRNSChange of Adviser
27th Dec 20237:00 amRNSAcquisition of HBFS
12th Dec 20237:00 amRNSAcquisition of Neba Businesses
9th Nov 202312:20 pmRNSHolding(s) in Company
8th Nov 20239:50 amRNSHolding(s) in Company
7th Nov 20234:40 pmRNSHolding(s) in Company
27th Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Sep 20237:00 amRNSLoan Note
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:02 amRNSAcquisition
1st Jun 20237:01 amRNSAcquisition
1st Jun 20237:00 amRNSHalf-year Report
31st Jan 20234:00 pmRNSResult of AGM
12th Jan 202311:30 amRNSNotice of AGM
11th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSFinal Results
26th Oct 20222:18 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSChange of Adviser
9th Aug 20224:45 pmRNSDirector/PDMR Shareholding
8th Aug 20229:03 amRNSAcquisition
4th Aug 20223:35 pmRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSCompletion of Acquisition
1st Jul 20221:45 pmRNSDirector/PDMR Shareholding
23rd Jun 20221:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:10 pmRNSResult of AGM
22nd Jun 20227:00 amRNSHalf-year Report
7th Jun 20229:15 amRNSNotice of AGM
16th May 20225:30 pmRNSDirector/PDMR Shareholding
16th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20227:05 amRNSChanges to Management Incentive Plan
12th May 20227:00 amRNSProposed Acquisition, Subscription &Trading Update
23rd Feb 20227:00 amRNSIssue of Equity
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:01 amRNSFinal Results
1st Dec 20217:00 amRNSAcquisition
5th Oct 202110:30 amRNSChange of Registered Office
26th Aug 20211:10 pmRNSDirector/PDMR Shareholding
10th Aug 202110:45 amRNSDirector/PDMR Shareholding
5th Jul 202111:05 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSAcquisition of JCAP Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.